CODX vs DXCM · rev $3.9M vs P/E 63, rev $4.03B
Co-Diagnostics, Inc. Common Stock (CODX) versus DexCom Inc (DXCM) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
DexCom Inc (DXCM) is a medical devices company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported DXCM revenue for 2024-12-31 was $4.03B. Net income was $576.2M. Revenue was up 11.3% from 2023-12-31 to 2024-12-31. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
CODX currently screens at market cap $31.4M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Not investment advice. Open the CODX and DXCM stock pages for the full models.
Not investment advice.